The proposed Charter Hall Direct Life Sciences Fund (LFS) is targeting a total return of +13% p.a.* and will provide exposure to essential life sciences real estate, supported by resilient, long-term sector demand.
The opportunity is underpinned by a long term 20-year lease to Sonic Healthcare, a globally recognised healthcare operator, with strong underlying demand drivers linked to essential medical services.
We will email you further details, including the Information Memorandum when the fund launches in or around July 2026.
If you have any questions in the meantime, please your Charter Hall representative below.
+13% p.a. target return*
Contact Us
Head of Distribution
National Strategic Account Manager
State Distribution Manager (NSW/Qld)
Senior Business Development Manager (Vic/SA/WA/Tas)
Business Development Manager (Vic/SA/WA)
Business Development Manager
Business Development Manager
Account Manager
Investor Communications Executive
Investor Communications Executive
Enquiries
Charter Hall Direct Property Management Limited ABN 56 073 623 784 AFSL 226849 (CHDPML) is expected to be the issuer of units in the proposed Charter Hall Direct Life Sciences Fund (LSF or Fund) for which an Information Memorandum (IM) is expected to be available around July 2026 at www.charterhall.com.au. You should consider the IM in deciding whether to acquire the product. This website is not an offer of units in the Fund or an offer to buy or sell any financial product and should not be relied on in making an investment decision. The information is general in nature and does not take into account your investment objectives, particular needs or financial situation. You should seek independent financial advice. Applications to invest can only be made using the application form relevant to the product. You can only apply to invest in the Fund if you are a wholesale client (within the meaning of that term under the Corporations Act 2001 (Cth). Whilst all care has been taken in preparation of this website, CHDPML does not give any representation or warranty as to the reliability, completeness or accuracy of the information contained on this website. CHDPML does not accept liability for any inaccurate, incomplete or omitted information of any kind or any losses caused by using this information. If you are a financial adviser, you should be aware that this website is only provided to you to give you information about the Fund to assist you to discharge your obligations under law in providing personal advice to your clients. The information in this website does not constitute, and should not be taken as constituting, personal advice by CHDPML and must not be used by you in any Statement of Advice or other advice to be provided by you to your clients in a manner that conveys this impression. If you provide a recommendation to your client about an interest in the Fund, you will need to consider this website, the IM, along with your obligations under law. This website may not be copied, reproduced, distributed or disseminated to any other person without the express prior approval of CHDPML. Past performance is not a reliable indicator of future performance. Any forward-looking statement in this website is predictive in character and may be affected by inaccurate assumptions or by known or unknown risks and uncertainties and may differ materially from results ultimately achieved.
*The target return is a target only. It is not a forecast and might not be achieved.
All figures on this website are as at 31 March 2026 and in Australian dollars unless otherwise stated.